Live News Categoriesequity

Optigenex Inc. (OPGX) News

Follow Optigenex Inc. (OPGX) news in one place: company catalysts, earnings, analyst actions and wider market developments. Review 1 public stories across 1 publication days to understand how the story developed. Public news appears after a 15-minute delay; LiveCast subscribers can follow new headlines and hear important updates without this additional delay.

Symbol OPGX Asset equity Sector Markets 90 days 0 Last 0.0003 Updated Jul 06, 2026, 01:53 PM UTC Open live news feed Open OPGX chart & news

L Opus Genetics FDA alignment further de-risks path to market, says Chardan After Opus Genetics announced that it has reached alignment with the FDA on the design of its registrational Phase 3 clinical trial evaluating OPGx-LCA5 for LCA5-associated IRD, an early-onset severe inherited retinal dy EQUITY | Jul 06, 2026, 01:53 PM UTC